IP Library Granted Patent US 7,914,824
Granted Patent B2
US 7,914,824 · App. 10/591,023 · Granted Mar 29, 2011

Herbal extract for renal disorders

Assignee: Piramal Life Sciences Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,914,824
App. No.
10/591,023
Granted
Mar 29, 2011
Kind
B2
Abstract

The present invention relates to the use of standardized extract of Tinospora cordifolia as an immunoadjuvant in the treatment of renal disorders such as nephrotic syndrome and chronic recurrent urinary tract infections, both complicated and uncomplicated. The present invention also relates to pharmaceutical compositions comprising the standardized extract of Tinospora cordifolia. The present invention further relates to a method of treatment of renal disorders such as recurrent urinary tract infection particularly occurring due to relapsing E. coli, Klebsiella and other gram negative infections and to a method of treatment of nephrotic syndrome using standardized extract of Tinospora cordifolia as an immunoadjuvant in conjunction with conventional therapy.

Claims (6)

1. A method for the treatment of a chronic recurrent urinary tract infection in a mammal in need thereof, the method comprising administering to the mammal a composition of a standardized extract of Tinospora cordifolia as an immunoadjuvant in a dosage of 20 to 80 mg/kg body weight per day of the mammal, in conjunction with an antibacterial agent over a period ranging from 20 days to three months.

2. The method of claim 1 , wherein the chronic recurrent urinary tract infection is both complicated and uncomplicated.

3. The method of claim 1 , wherein the chronic recurrent urinary tract infection is caused due to relapsing bacterial infection.

4. The method of claim 3 , wherein the relapsing bacterial infection is E. coli or Klebsiella infection.

5. The method of claim 1 , wherein said composition comprising the standardized extract of Tinospora cordifolia is administered in a dosage of 20-25 mg/kg body weight over a period of one month.

6. The method of claim 1 , wherein said antibacterial agent is selected from the group consisting of ciprofloxacin, ofloxacin, norfloxacin, trimethoprim, sulfamethoxazole, amoxicillin, nitrofurantoin, ampicillin and lomefloxacin.

Assignments (5)
CHANGE OF NAME Recorded May 8, 2013
From: PIRAMAL HEALTHCARE LIMITED
To: PIRAMAL ENTERPRISES LIMITED
Reel/Frame 030376/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2013
From: PIRAMAL LIFE SCIENCES LIMITED
To: PIRAMAL HEALTHCARE LIMITED
Reel/Frame 030351/0847 →
CHANGE OF NAME Recorded Nov 5, 2009
From: NICHOLAS PIRAMAL INDIA LIMITED
To: PIRAMAL HEALTHCARE LIMITED
Reel/Frame 023481/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2009
From: PIRAMAL HEALTHCARE LIMITED
To: PIRAMAL LIFE SCIENCES LIMITED
Reel/Frame 023481/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2008
From: ACHARYA, VIDYA NARAYAN; MUKHOPADHYAY, TRIPTIKUMAR; PIRAMAL, SWATI AJAY
To: NICHOLAS PIRAMAL INDIA LIMITED
Reel/Frame 021167/0956 →
Continuity (2)
Provisional Application 60561335 · Apr 9, 2004
Related Publication 20080274212A1 · Nov 6, 2008